IAC Express 2008 |
Issue number 740: July 7, 2008 |
|
Contents
of this Issue
Select a title to jump to the article. |
- New: CDC
posts the provisional recommendations for use of rotavirus vaccine on the
ACIP web section
- IAC
reviews and revises several of its hepatitis A and B resources and one
resource on vaccine storage and handling
- New:
"Questions Parents Ask about Baby Shots" now in Spanish, Arabic, Chinese,
French, Korean, Russian, and Vietnamese
- New
Jersey and Vermont expand school vaccination requirements; West Virginia
allows pharmacists to vaccinate
- American
Journal of Medicine publishes a supplement on expanding the influenza
vaccination season
- CDC's
QuickStats charts percentage of adults age >=65 years who ever received
pneumococcal vaccine by sex, age group, and race/ethnicity
- Summer
meeting of the Chicago Area Immunization Campaign scheduled for July 23 in
Chicago
- MMWR
issues correction to the ACIP recommendations "Prevention of Pertussis,
Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their
Infants"
|
|
Abbreviations |
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
|
Issue 740: July 7, 2008 |
|
|
1. |
New: CDC posts the provisional recommendations for use of rotavirus vaccine
on the ACIP web section
On July 1, CDC posted provisional
recommendations for the
prevention of rotavirus gastroenteritis among infants and
children. They are reprinted below in their entirety.
Note: Provisional recommendations are those ACIP has voted on
but that are not yet approved by CDC or the Department of Health
and Human Services and have not yet been published in MMWR.
ACIP PROVISIONAL RECOMMENDATIONS FOR THE PREVENTION OF ROTAVIRUS
GASTROENTERITIS AMONG INFANTS AND CHILDREN
Date of ACIP vote: June 25, 2008
Date of posting of provisional recommendations: July 1, 2008
A new rotavirus vaccine [Rotarix (GlaxoSmithKline Biologicals)]
was licensed on April 3, 2008, for use in the United States. On
June 25, 2008, the ACIP voted on new recommendations for the use
of rotavirus vaccine for the prevention of rotavirus
gastroenteritis among infants and children.
The new provisional recommendations for the use of rotavirus
vaccine follow:
Routine Administration
- For routine vaccination of U.S. infants, two different
rotavirus vaccine products are licensed: RotaTeq (Merck & Co)
(RV5) and Rotarix (GSK) (RV1). The products differ in
composition and schedule of administration. ACIP does not
express a preference for RV5 or RV1.
- RV5 is to be administered orally in a 3-dose series with doses
given at ages 2, 4, and 6 months. RV1 is to be administered
orally in a 2-dose series with doses given at ages 2 and 4
months. The first dose of rotavirus vaccine should be
administered from age 6 weeks through age 14 weeks 6 days (the
maximum age for the first dose is 14 weeks 6 days).
Vaccination should not be initiated for infants of age 15
weeks 0 days or older. The minimum interval between doses of
rotavirus vaccine is 4 weeks. All doses should be administered
by age 8 months 0 days.
Interchangeability of Rotavirus Vaccines
- ACIP recommends that the rotavirus vaccine series be completed
with the same product whenever possible. However, vaccination
should not be deferred if the product used for previous doses
is not available or is unknown. In this situation, the
provider should continue or complete the series with the
product available.
- If any dose in the series was RV5 or the product is unknown
for any dose in the series, a total of three doses of
rotavirus vaccine should be given.
Contraindications
- Rotavirus vaccine should not be administered to infants who
have a history of a severe allergic reaction (e.g.,
anaphylaxis) after a previous dose of rotavirus vaccine or to
a vaccine component. Latex rubber is contained in the RV1 oral
applicator, so infants with a severe (anaphylactic) allergy to
latex should not receive RV1. The RV5 dosing tube is latex-free.
The 2006 ACIP recommendations for the prevention or rotavirus
gastroenteritis among infants and children are available at
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5512a1.htm
The Rotarix package insert is available at
http://www.fda.gov/cber/label/rotarixLB.pdf
To access the RotaTeq package insert, go to:
http://www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi.pdf
To access a ready-to-print (PDF) version of the provisional
recommendations, go to:
http://www.cdc.gov/vaccines/recs/provisional/downloads/roto-7-1-08-508.pdf
All provisional ACIP recommendations can be found at
http://www.cdc.gov/vaccines/recs/provisional
A chronological listing of all published ACIP recommendations is
available at
http://www.immunize.org/acip
An alphabetical listing of all published ACIP recommendations is
available at
http://www.immunize.org/acip/vacpolicy_vax.asp
Back to top |
|
|
2. |
IAC reviews and revises several of its hepatitis A and B resources and one
resource on vaccine storage and handling
IAC recently reviewed and revised several of its
hepatitis A and
B print resources and one resource on vaccine storage and
handling. Links to all follow.
VIRAL HEPATITIS A AND B RESOURCES
"Hepatitis A: Questions and Answers--information about the
disease and vaccines." Changes were made to information about
the use of immune globulin and/or hepatitis A vaccine prior to
travel.
To access "Hepatitis A: Questions and Answers--information about
the disease and vaccines," go to:
http://www.immunize.org/catg.d/p4204.pdf
Note: This resource is also available in web-text format on
IAC's www.vaccineinformation.org website at
http://www.vaccineinformation.org/hepa/qandadis.asp
"Hepatitis B Information for Asian Americans and Pacific
Islanders" was extensively revised.
To access "Hepatitis B Information for Asian Americans and
Pacific Islanders," go to:
http://www.immunize.org/catg.d/p4190.pdf
"Should You Be Vaccinated Against Hepatitis A? A screening
questionnaire for adults." This risk-assessment statement was
added: "I might have been exposed to the hepatitis A virus in
the past two weeks."
To access "Should You Be Vaccinated Against Hepatitis A? A
screening questionnaire for adults," go to:
http://www.immunize.org/catg.d/p2190.pdf
"Hospitals & Doctors Sued for Failing to Protect Newborns from
Hepatitis B Virus Transmission" was reviewed and found to be
still accurate.
To access "Hospitals & Doctors Sued for Failing to Protect
Newborns from Hepatitis B Virus Transmission," go to:
http://www.immunize.org/catg.d/p2061.pdf
"Hospitals and Doctors Sued for Failing to Immunize" was
reviewed and found to be still accurate.
To access "Hospitals and Doctors Sued for Failing to Immunize,"
go to: http://www.immunize.org/catg.d/p2060.pdf
VACCINE STORAGE AND HANDLING RESOURCE
"Don't Be Guilty of These Errors in Vaccine Storage and
Handling" was reviewed and found to be still accurate.
To access "Don't Be Guilty of These Errors in Vaccine Storage
and Handling," go to: http://www.immunize.org/catg.d/p3036.pdf
IAC's Print Materials web section has more than 175 FREE,
English-language, ready-to-print resources for healthcare
professionals and the public. To access them, go to:
http://www.immunize.org/printmaterials
Note: The web address above will also take you to many IAC print
materials in translation.
Back to top |
|
|
3. |
New: "Questions Parents Ask about Baby Shots" now in Spanish, Arabic,
Chinese, French, Korean, Russian, and Vietnamese
The IAC website now has translations of the
parent-education
brochure "Questions Parents Ask about Baby Shots" in seven
languages in addition to English. The languages are Spanish,
Arabic, Chinese, French, Korean, Russian, and Vietnamese. Links
to all follow.
To access the Spanish version of "Questions Parents Ask about
Baby Shots" go to: http://www.immunize.org/catg.d/p4025-01.pdf
To access the Arabic version of "Questions Parents Ask about
Baby Shots" go to: http://www.immunize.org/catg.d/p4025-20.pdf
To access the Chinese version of "Questions Parents Ask about
Baby Shots" go to: http://www.immunize.org/catg.d/p4025-08.pdf
To access the French version of "Questions Parents Ask about
Baby Shots" go to: http://www.immunize.org/catg.d/p4025-10.pdf
To access the Korean version of "Questions Parents Ask about
Baby Shots" go to: http://www.immunize.org/catg.d/p4025-09.pdf
To access the Russian version of "Questions Parents Ask about
Baby Shots" go to: http://www.immunize.org/catg.d/p4025-07.pdf
To access the Vietnamese version of "Questions Parents Ask about
Baby Shots" go to: http://www.immunize.org/catg.d/p4025-05.pdf
To access the English version of "Questions Parents Ask about
Baby Shots" go to: http://www.immunize.org/catg.d/p4025.pdf
To access additional FREE, ready-to-print translations from the
IAC website, go to:
http://www.immunize.org/printmaterials/translations.asp
IAC's Print Materials web section has more than 175 FREE, ready-to-print resources for healthcare professionals and the public.
To access them, go to:
http://www.immunize.org/printmaterials
Back to top |
|
|
4. |
New Jersey and Vermont expand school vaccination requirements; West Virginia
allows pharmacists to vaccinate
New Jersey now requires childcare enrollees to be
vaccinated
against influenza and pneumococcal disease, and Vermont requires
students to be vaccinated against varicella and hepatitis B
virus infection. Both states require students to be vaccinated
against meningococcal disease and against tetanus, diphtheria,
and pertussis. West Virginia permits pharmacists to administer
influenza and pneumococcal vaccines to adults. More detailed
information follows.
INFLUENZA VACCINATION
New Jersey: Children attending licensed child care centers and
preschools are required to show annual vaccination against
influenza, effective September 2008. New Jersey is the first
state in the nation to require children in this age group to
receive annual influenza vaccination.
PNEUMOCOCCAL VACCINATION
New Jersey: Children attending licensed child care centers and
preschools are required to be vaccinated with pneumococcal
conjugate vaccine (PCV), effective September 2008.
IAC has compiled a table of information about all states that
have pneuomococcal conjugate vaccination mandates for children
in day care facilities. To access the information, go to:
http://www.immunize.org/laws/pneuconj.asp
This information is also depicted visually on a map of the
United States. To access the map, go to:
http://www.immunize.org/pdfs/pcv7.pdf
VARICELLA (CHICKENPOX) VACCINATION
Vermont: Students entering either kindergarten or grade 7 are
required to have received two doses of varicella vaccine
(disease history may be substituted for vaccine). A new
requirement for post-secondary schools includes two doses of
varicella vaccine or evidence of disease. The new requirements
are effective August 2008.
With the addition of Vermont, the total number of states now
requiring varicella vaccination or proof of disease in day care,
elementary, or middle schools has increased to 48. Only Idaho
and Wyoming do not have requirements.
IAC has compiled a table of information about all states that
have varicella prevention mandates for children in day care
facilities and for students in elementary, middle school, and
junior high. To access the information, go to:
http://www.immunize.org/laws/varicel.asp
This information is also depicted visually on a map of the
United States. To access the map, go to:
http://www.immunize.org/pdfs/varicella.pdf
HEPATITIS B VACCINE
Vermont: Students entering kindergarten and post-secondary
schools are required to have received three doses of hepatitis B
vaccine; since 1999, children entering grade 7 have been
required to be vaccinated against hepatitis B. The requirements
for kindergarten and post-secondary school attendance become
effective August 2008.
IAC has compiled a table of information about all states that
have hepatitis B prevention mandates for children in day care
facilities and students in elementary and middle school. To
access the information, go to:
http://www.immunize.org/laws/hepb.asp
This information is also depicted visually on a map of the
United States. To access the map, go to:
http://www.immunize.org/pdfs/hepb.pdf
IAC has compiled a table of information about all states that
have hepatitis B prevention mandates for students in post-secondary schools. To access the information, go to:
http://www.immunize.org/laws/hepbcollege.asp
This information is also depicted visually on a map of the
United States. To access the map, go to
http://www.immunize.org/pdfs/hepb_college.pdf
MENINGOCOCCAL VACCINE
New Jersey: Students born after January 1, 1997, and enrolled in
grade 6, are required to show documentation of one dose of
meningococcal vaccine, effective September 2008.
Vermont: Students who are entering grades 7-12, and who will be
living in a residential-based school, are required to have
received one dose of meningococcal vaccine. First-year post-secondary students who will be living in dormitories are also
required to have received one dose of meningococcal vaccine. The
meningococcal requirements become effective August 2008.
Note: Both a table and a map of this information are under
development.
TETANUS-DIPHTHERIA-ACELLULAR PERTUSSIS VACCINE
New Jersey: Students born after January 1, 1997, and enrolled in
grade 6 are required to show documentation of one dose of Tdap
vaccine, effective September 2008.
Vermont: Students entering grade 7 are required to have had a
one-time dose of Tdap vaccine, effective August 2008.
Note: Both a table and a map of this information are under
development.
PHARMACIST AUTHORIZATION TO VACCINATE
West Virginia: Pharmacists are now authorized to administer
influenza and pneumococcal vaccines to adults age 18 and older
under a new West Virginia state law.
IAC has compiled a table of information about all states that
authorize pharmacists to vaccinate. To access the information,
go to:
http://www.immunize.org/laws/pharm.asp
This information is also depicted visually on a map of the
United States. To access the map, go to
http://www.immunize.org/pdfs/pharm.pdf
IAC Express depends on readers to help us stay informed and
ensure our website contains the most current and accurate
information available. Please let us know when any changes occur
in your state by emailing us at admin@immunize.org
Back to top |
|
|
5. |
American Journal of Medicine publishes a supplement on expanding the
influenza vaccination season
The American Journal of Medicine (AJM) has
devoted one of its
July Supplements to "Expanding the Influenza Vaccination Season:
A New Paradigm for Increasing Immunization Rates." The
supplement is free and can be downloaded. AJM is a publication
of the Association of Professors of Medicine.
Following is a list of the supplement's chapter titles and
authors:
-
Introduction: Expanding the Influenza Season, by William
Schaffner
-
Increasing Influenza Vaccination Rates: The Need to Vaccinate
Throughout the Entire Influenza Season, by Gregory A. Poland
and David R. Johnson
-
Practice-Proven Interventions to Increase Vaccination Rates
and Broaden the Immunization Season, by Patricia K.
Stinchfield
-
Lessons Learned: Role of Influenza Vaccine Production,
Distribution, Supply, and Demand--What It Means for the
Provider, by Walter A. Orenstein and William Schaffner
-
Barriers to Adult Immunization, by David R. Johnson, Kristin
L. Nichol, and Kim Lipczynski
To access the supplement, which can be downloaded by chapter, go
to:
http://www.amjmed.com/issues/contents?issue_key=S0002-9343(08)X0012-9
Back to top |
|
|
6. |
CDC's QuickStats charts percentage of adults age >=65 years who ever received
pneumococcal vaccine by sex, age group, and race/ethnicity
As part of its QuickStats series, CDC published
"Percentage of
Adults Aged >=65 Years Who Ever Received a Pneumococcal
Vaccination, by Sex, Age Group, and Race/Ethnicity--National
Health Interview Survey, United States, 2007" in the July 4
issue of MMWR. Presented in graph format, QuickStats provides
updates on key indicators and important trends in public health.
They are based on survey data from the National Center for
Health Statistics. The text of the QuickStats that appeared in
the July 4 MMWR is reprinted below in its entirety, excluding
references.
In 2007, approximately 58% of adults aged >=65 years had ever
received a pneumococcal vaccination. In this population,
statistically significant differences by sex, age group, and
race/ethnicity were observed. Women were more likely than men to
have ever received a pneumococcal vaccination. Adults aged >=75
years were more likely to have ever received a pneumococcal
vaccination compared with adults aged 65-74 years. Non-Hispanic
white adults aged >=65 years were more likely than Hispanic and
non-Hispanic black adults in that age group to have received the
vaccination.
SOURCE: Heyman KM, Schiller JS, Barnes P. Early release of
selected estimates based on data from the 2007 National Health
Interview Survey. U.S. Department of Health and Human Services,
CDC, National Center for Health Statistics; 2008. Available at
http://www.cdc.gov/nchs/about/major/nhis/released200806.htm
To access a web-text (HTML) version of the complete QuickStats,
go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5726a4.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5726.pdf
To receive a FREE electronic subscription to MMWR (which
includes new ACIP recommendations), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
|
|
7. |
Summer meeting of the Chicago Area Immunization Campaign scheduled for July
23 in Chicago
The Chicago Area Immunization Campaign will hold
its summer
meeting on July 23 in Chicago at St. Mary & Elizabeth Medical
Center. The special guest speaker is Gary S. Marshall, MD,
professor of pediatrics; chief, Division of Pediatric Infectious
Diseases, University of Louisville School of Medicine,
Louisville, KY.
To access a registration form, go to:
http://www.ilmaternal.org/CAIC/Misc/summer08generalmtg.pdf
For additional information, contact Melissa Ponce at (312) 491-8161.
Back to top |
|
|
8. |
MMWR
issues correction to the ACIP recommendations "Prevention of Pertussis, Tetanus,
and Diphtheria Among Pregnant and Postpartum Women and Their Infants"
CDC published "Erratum: Vol. 57, No. RR-4" in the
July 4 issue
of MMWR. The erratum concerns "Prevention of Pertussis, Tetanus,
and Diphtheria Among Pregnant and Postpartum Women and Their
Infants: Recommendations of the Advisory Committee on
Immunization Practices (ACIP)," which was published on May 30 as
an MMWR Recommendations and Reports. The erratum is reprinted
below in its entirety.
In the MMWR Recommendations and Reports (Vol. 57, No. RR-4),
"Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant
and Postpartum Women and Their Infants: Recommendations of the
Advisory Committee on Immunization Practices (ACIP)," an error
occurred on page 4 in Table 1. For the vaccine ADACEL, the
fimbriae component of the formulation was omitted; it should be
5 [micrograms], followed by the [three paragraph marks] footnote
symbol.
To access a web-text (HTML) version of the erratum, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5726a3.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5726.pdf
To access a ready-to-print (PDF) version of the May 30 ACIP
recommendations "Prevention of Pertussis, Tetanus, and
Diphtheria Among Pregnant and Postpartum Women and Their
Infants," go to: http://www.cdc.gov/mmwr/PDF/rr/rr5704.pdf
Back to top |
|
|
|